Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM-364 in Advanced Solid Tumors
NCT07694765Phase 2Not yet recruiting
- Sponsor
- LaNova Medicines
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of LM-364 in solid tumor, sponsored by LaNova Medicines. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
LM-364
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07694765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07694765.